Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Hybrid Type III Effectiveness - Implementation, Pragmatic Intervention Trial for Cervical Cancer Screen and Treat in Mozambique

NCT06810739 is registered in ClinicalTrials.gov with Tulane University as lead sponsor.

NCT NCT06810739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06810739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Hybrid Type III Effectiveness - Implementation, Pragmatic Intervention Trial for Cervical Cancer Screen and Treat in Mozambique
Lead sponsor
Tulane University
Phase
Not applicable
Overall status
Recruiting
Start date
July 13, 2026
Completion date
August 31, 2028
Enrollment
8,445 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papilloma virus related cervical carcinoma